Sharp Decline in Life Sciences Industry Investments in Israel in 2025
A newly published report presents a complex picture of the state of the Health-Tech industry in Israel. While 2024 showed signs of economic recovery, the latest data for 2025 points to a significant shift in the sector's trend.
According to the report, there has been a sharp 40% decline in the volume of investments in Israeli life sciences companies over the past year. This is a significant figure that indicates growing difficulty for companies in the field to raise capital from investors, following the positive period recorded the previous year.
In addition to the overall decline in investments, the report points to a continuing trend of a decrease in the average amount invested in each individual deal. This means that companies in the medical technology sector are forced to contend with fewer financial resources compared to the past, which could affect their ability to develop new products.
Despite the concerning investment data, the report notes that relative stability is being maintained in the export sector. This figure indicates that the products and services of Israeli life sciences companies still enjoy demand in international markets, even during a challenging economic period.
The industry is now examining how to cope with the decline in available capital. Market experts are closely monitoring the data to understand whether this is a temporary shift or a long-term trend that will affect the future of medical innovation in Israel in the coming years.